MedBridge Ranked 468th Fastest-Growing Company in North America on Deloitte’s 2020 Technology Fast 500™

MedBridge has been honored for its 192 percent revenue growth, driven by its innovative virtual engagement solutions that expand access to care while improving clinical and patient outcomes at a lower cost.

MedBridge today announced that it ranked 468th on Deloitte’s Technology Fast 500™, a list of the 500 fastest-growing technology, media, telecommunications, life sciences and energy tech companies in North America, now in its 26th year. MedBridge grew 192 percent during the award period. 

MedBridge is the industry-leading professional development and patient engagement solution that enables healthcare organizations to improve outcomes and optimize care delivery.

MedBridge’s founder and chief executive officer, Justin Kowalchuk, credits the company’s recent dynamic growth to its innovative digital care solutions, including telehealth. “Over the last year, our virtual engagement solutions have allowed our healthcare clients to continue providing essential access to care. With the ability to reach patients in their homes, our clients can provide continuous care and a hiqh-quality patient experience with limited disruption to patient flows,” said Kowalchuk. “We’re honored to receive this award and for the opportunity to partner with our clients to help improve lives during these unprecedented times. We’re grateful to them and to our dedicated employees for helping to make this possible.” 

As part of an integrated digital patient engagement platform, Telehealth Virtual Visits allows providers to share prescribed exercises and education with patients in real time, while tracking and monitoring patient adherence to home programs. Organizations adopting the MedBridge digital patient engagement solution have seen staggering results from improved satisfaction and wait times to decreased number of visits needed per episode of care. 

One client used Virtual Visits to launch a virtual care clinic that reduced cost per episode of care by 47 percent, improved functional outcomes in 98 percent of patients, and saw a decrease in pain for 93 percent of patients. 

“For more than 25 years, we’ve been honoring companies that define the cutting edge and this year’s Technology Fast 500 list is proof positive that technology — from software and digital media platforms, to biotech — truly does permeate so many facets of our lives,” said Paul Silverglate, vice chairman, Deloitte LLP and U.S. technology sector leader. “We congratulate this year’s winners, especially during a time when innovation is needed more than ever to address the monumental challenges posed by the pandemic.”

“Each year the Technology Fast 500 listing validates how important technology innovation is to our daily lives. It was interesting to see this year that while software companies continued to dominate, biotech companies rose to the top of the winners list for the first time, demonstrating that new categories of innovation are accelerating in the pursuit of making life easier, safer and more productive,” said Mohana Dissanayake, partner, Deloitte & Touche LLP, and industry leader for technology, media and telecommunications, within Deloitte’s audit and assurance practice. “We extend sincere congratulations to these well-deserved winners — who all embody a spirit of curiosity, and a never-ending commitment to making technology advancements possible.”

This is the first year that MedBridge has been a Technology Fast 500™ award winner, marking a period of rising growth and increasing dynamic innovation for the company. 

About Deloitte’s 2020 Technology Fast 500™

Now in its 26th year, Deloitte’s Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2016 to 2019.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or technology that is sold to customers in products that contribute to a majority of the company’s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million. Additionally, companies must be in business for a minimum of four years and be headquartered within North America.

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee (“DTTL”), its network of member firms, and their related entities. DTTL and each of its member firms are legally separate and independent entities. DTTL (also referred to as “Deloitte Global”) does not provide services to clients. In the United States, Deloitte refers to one or more of the US member firms of DTTL, their related entities that operate using the “Deloitte” name in the United States and their respective affiliates. Certain services may not be available to attest clients under the rules and regulations of public accounting. Please see www.deloitte.com/about to learn more about our global network of member firms.

Source: MedBridge